Increased inflammatory markers, particularly IL-6, have been associated with specific symptoms of depression, such as hypersomnia, fatigue, leaden paralysis, and hyperphagia, which could have negatively affected patients’ adherence to the proposed intervention, specifically by reducing their ability and motivation to move toward natural green environments (114–116). Here, IL6 is linked to depressive symptom measurement.